Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 3, 2013, Pages 169-182

  Kang, Eun Ju ^a   Lee, Young Hyurk ^b   Kim, Min Jeong ^a   Lee, Yeon Mi ^a   Mohana Kumar, B ^a   Jeon, Byeong Gyun ^a   Ock, Sun A ^a   Kim, Hyun Joon ^b   Rho, Gyu Jin ^a  

^a Gyeongsang National University   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Bone marrow; Mesenchymal stem cells; Miniature pig; Mouse; Parkinson's disease; Umbilical cord matrix

Indexed keywords

AMINO ACIDS; BONE; CELL ENGINEERING; CELL MEMBRANES; ENDOTHELIAL CELLS; FLOWCHARTING; MAMMALS; NEURODEGENERATIVE DISEASES; NEURONS; STEM CELLS;

BONE MARROW; DISEASE MODELS; IN-VITRO; MATRIX; MESENCHYMAL STEM CELL; MINIATURE PIG; MOUSE; PARKINSON'S DISEASE; UMBILICAL CORD MATRIX; UMBILICAL CORDS;

CELL CULTURE;

BETA TUBULIN; BETA1 INTEGRIN; HERMES ANTIGEN; INTERLEUKIN 6; MICROTUBULE ASSOCIATED PROTEIN 2; NESTIN; NEURON SPECIFIC NUCLEAR PROTEIN; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOPLASM; EXPERIMENTAL PIG; IMMUNOGENICITY; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; OSTEOCYTE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAROD TEST; SUBSTANTIA NIGRA; XENOTRANSPLANTATION;

EID: 84874737643     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.504     Document Type: Article

References (51)

1. Alvarez-Fischer D, Henze C, Strenzke C, et al. 2008; Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice. Exp Neurol 210(1): 182-193.
2. Barda-Saad M, Rozenszajn LA, Ashush H, et al. 1999; Adhesion molecules involved in the interactions between early T cells and mesenchymal bone marrow stromal cells. Exp Hematol 27(5): 834-844.
3. Barnabe GF, Schwindt TT, Calcagnotto ME, et al. 2009; Chemically induced RAT mesenchymal stem cells adopt molecular properties of neuronal-like cells but do not have basic neuronal functional properties. PLoS One 4(4): e5222.
4. Bernheimer H, Birkmayer W, Hornykiewicz O, et al. 1973; Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20(4): 415-455.
5. Blandini F, Cova L, Armentero MT, et al. 2010; Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant 19(2): 203-217.
6. Caplan AI. 2009; Why are MSCs therapeutic? New data: new insight. J Pathol 217(2): 318-324.
7. Carlin R, Davis D, Weiss M, et al. 2006; Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol 4: 8.
8. Cho PS, Messina DJ, Hirsh EL, et al. 2008; Immunogenicity of umbilical cord tissue derived cells. Blood 111(1): 430-438.
9. Cova L, Armentero MT, Zennaro E, et al. 2010; Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res 1311: 12-27.
10. da Conceicao FSL, Ngo-Abdalla S, Houzel J, et al. 2010; Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test. J Vis Exp 35: 1376.
11. Dezawa M, Kanno H, Hoshino M, et al. 2004; Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113(12): 1701-1710.
12. Franklin KBJ, Paxinos G. 1997; The Mouse Brain in Stereotaxic Coordinates. Academic Press: New York.
13. Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970; The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3(4): 393-403.
14. Fu YS, Cheng YC, Lin MY, et al. 2006; Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24(1): 115-124.
15. Grealish S, Mattsson B, Draxler P, et al. 2010; Characterization of behavioral and neurodegenrative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. Eur J Neurosci 31(12): 2266-2278.
16. Hoppo T, Fujii H, Hirose T, et al. 2004; Thy1-positive mesenchymal cells promote the maturation of CD49f-positive hepatic progenitor cells in the mouse fetal liver. Hepatology 39(5): 1362-1370.
17. Huang T, He D, Kleiner G, et al. 2007; Neuron-like differentiation of adipose-derived stem cells from infant piglets in vitro. J Spinal Cord Med 30(suppl 1): S35.
18. Iancu R, Mohapel P, Brundin P, et al. 2005; Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 162(1): 1-10.
19. Jones DG, Redpath CM. 1998; Regeneration in the central nervous system: pharmacological intervention, xenotransplantation, and stem cell transplantation. Clin Anat 11(4): 263-270.
20. Joyal CC, Meyer C, Jacquart G, et al. 1996; Effects of midline and lateral cerebellar lesions on motor coordination and spatial orientation. Brain Res 739(1-2): 1-11.
21. Kang EJ, Byun JH, Choi YJ, et al. 2010; In vitro and in vivo osteogenesis of porcine skin-derived mesenchymal stem cell-like cells with a demineralized bone and fibrin glue scaffold. Tissue Eng A 16(3): 815-827.
22. Karahuseyinoglu S, Cinar O, Kilic E, et al. 2007; Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25(2): 319-331.
23. Kishimoto T. 2010; IL-6: from its discovery to clinical applications. Int Immunol 22(5): 347-352.
24. Krampera M, Marconi S, Pasini A, et al. 2007; Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone 40(2): 382-390.
25. Kumar BM, Jin HF, Kim JG, et al. 2007; Differential gene expression patterns in porcine nuclear transfer embryos reconstructed with fetal fibroblasts and mesenchymal stem cells. Dev Dyn 236(2): 435-446.
26. Larsson LC, Frielingsdorf H, Mirza B, et al. 2001; Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection. Exp Neurol 172(1): 100-114.
27. Li JY, Christophersen NS, Hall V, et al. 2008; Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci 31(3): 146-153.
28. Li XZ, Bai LM, Yang YP, et al. 2009; Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation. Neurosci Res 65(3): 252-258.
29. Lu P, Blesch A, Tuszynski MH. 2004; Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res 77(2): 174-191.
30. Medicetty S, Bledsoe AR, Fahrenholtz CB, et al. 2004; Transplantation of pig stem cells into rat brain: proliferation during the first 8weeks. Exp Neurol 190(1): 32-41.
31. Mitchell KE, Weiss ML, Mitchell BM, et al. 2003; Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21(1): 50-60.
32. Montzka K, Lassonczyk N, Tschoke B, et al. 2009; Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression. BMC Neurosci 10: 16.
33. Nekanti U, Rao VB, Bahirvani AG, et al. 2010; Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev 19(1): 117-130.
34. Obeso JA, Olanow CW, Nutt JG. 2000; Levodopa motor complications in Parkinson's disease. Trends Neurosci 23: S2.
35. Ourednik J, Ourednik V, Lynch WP, et al. 2002; Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 20(11): 1103-1110.
36. Piriou-Guzylack L, Salmon H. 2008; Membrane markers of the immune cells in swine: an update. Vet Res 39(6): 54.
37. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-147.
38. Rho GJ, Kumar BM, Balasubramanian S. 2009; Porcine mesenchymal stem cells - current technological status and future perspective. Front Biosci 14: 3942-3961.
39. Roy NS, Cleren C, Singh SK, et al. 2006; Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12(11): 1259-1268.
40. Rozas G, Labandeira Garcia JL. 1997; Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Brain Res 749(2): 188-199.
41. Sackstein R, Merzaban JS, Cain DW, et al. 2008; Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14(2): 181-187.
42. Santini E, Valjent E, Fisone G. 2008; Parkinson's disease: levodopa-induced dyskinesia and signal transduction. FEBS J 275(7): 1392-1399.
43. Sonntag KC, Pruszak J, Yoshizaki T, et al. 2007; Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 25(2): 411-418.
44. Studer L, Tabar V, McKay RD. 1998; Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1(4): 290-295.
45. Vacanti V, Kong E, Suzuki G, et al. 2005; Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 205(2): 194-201.
46. Vidaltamayo R, Bargas J, Covarrubias L, et al. 2010; Stem cell therapy for Parkinson's disease: a road map for a successful future. Stem Cells Dev 19(3): 311-320.
47. Weiss ML, Medicetty S, Bledsoe AR, et al. 2006; Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24(3): 781-792.
48. Weiss ML, Mitchell KE, Hix JE, et al. 2003; Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neur 182(2): 288-299.
49. Wernig M, Zhao JP, Pruszak J, et al. 2008; Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Nat Acad Sci USA 105(15): 5856-5861.
50. Woodbury D, Schwarz EJ, Prockop DJ, et al. 2000; Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4): 364-370.
51. Yasuhara T, Shingo T, Muraoka K, et al. 2005; Neurorescue effects of VEGF on a rat model of Parkinson's disease. Brain Res 1053(1-2): 10-18.